Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis.

Shao, Zitong; Chow, Michael Y T; Chow, Shing Fung; Lam, Jenny K W

Shao, Zitong; Chow, Michael Y T; Chow, Shing Fung; Lam, Jenny K W.

Afiliación

Shao Z; Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR.
Chow MYT; Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR.
Chow SF; Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK.
Lam JKW; Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR.

Pharm Res ; 40(5): 1073-1086, 2023 May.

Article en En | MEDLINE | ID: mdl-36869245

Asunto(s)

Mycobacterium tuberculosis; Tuberculosis Resistente a Múltiples Medicamentos; Humanos; Capreomicina/química; Capreomicina/uso terapéutico; Polvos/química; Péptidos Antimicrobianos; Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico; Tuberculosis Resistente a Múltiples Medicamentos/microbiología; Aerosoles/química; Péptidos/farmacología; Inhaladores de Polvo Seco/métodos; Tamaño de la Partícula; Administración por Inhalación

Palabras clave

antimicrobial peptide; capreomycin; drug-resistant tuberculosis; dry powder aerosol; spray drying

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Mycobacterium tuberculosis Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google